|
"dito e"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2013-08-20 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, A. H.; Tempero, M. A.; Shan, Y-S; Su, W-C; Lin, Y-L; Dito, E.; Ong, A.; Wang, Y-W; Yeh, C. G.; Chen, L-T |
| 國家衛生研究院 |
2013-08 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;Chen, LT |
| 高雄醫學大學 |
2013 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer.
|
Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;陳立宗; Ko, AH;Tempero, MA;Shan, YS;Su, WC;Lin, YL;Dito, E;Ong, A;Wang, YW;Yeh, CG;Chen, LT. |
| 國家衛生研究院 |
2011-02 |
A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, AH;Tempero, MA;Shan, Y;Su, W;Lin, Y;Dito, E;Ong, A;Yeh, G;Chen, L |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
